Using Imaging Biomarkers in Clinical Practice

(17:4)

Implementing MS imaging biomarkers into everyday practice

(1:23)

Novel Imaging Biomarkers for Dementia Therapeutics

(58:46)

Imaging Biomarkers - Dr. Stephanie Tanadini-Lan

(26:58)

2019 FNIH Biomarkers Consortium Neuroscience Symposium Session 3 - Imaging Biomarkers

(2:55:22)

[MISS 2016] Marleen de Bruijne - Learning imaging biomarkers: challenges and pitfalls

(1:10:33)

Webinar: Overcoming the challenges in deploying new imaging biomarkers in clinical trials

(59:32)

Edward Jackson: The Evolution of Medical Imaging from Qualitative to Quantitative

(48:15)

Role of imaging biomarkers of myelin repair in the development of neuroprotective drugs

(43)

Lecture 1. Introducing imaging biomarkers for prostate cancer care

(31:57)

PSA limitations in prostate cancer: advancing treatment de-escalation with imaging biomarkers

(1:24)

Translating MS imaging biomarkers into clinical practice

(1:41)

Implementation of novel imaging biomarkers in clinical practice

(1:52)

Translation of Quantitative Imaging Biomarkers into Clinical Chest CT

(4:27)

IDIBAPS researcher David Fuster explains his research on multimodal imaging biomarkers

(2:15)

Highlights from PROSCA 2018: Imaging, biomarkers and genetic testing

(12:54)

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

(55:19)

Hyperpolarized Molecular Imaging Biomarkers and Prostate Cancer

(5:8)

Imaging “Biomarkers” – Are We There Yet?

(14:42)

Parkinson’s disease: key updates in imaging biomarkers

(3:7)